241 top medical experts on Ocular Paraneoplastic Syndromes across 26 countries and 20 U.S. states, including 139 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Ocular Paraneoplastic Syndromes: Ocular manifestations secondary to various neoplasms in which antibodies to antigens of the primary tumor cross-react with ocular antigens. This autoimmune response often leads to visual loss and other ocular dysfunctions.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Eye Neoplasms (1,722), Paraneoplastic Syndromes (4,609).


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Sobrin, Lucia   Ophthalmology   Google Publications
    Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts. Electronic address: . Top Hospital
    Physician  Highly Published 
    Medical school: University of Miami, Lm Miller School of Medicine (MD, 1999)
    Medicare Accepted
    Disclosed payments in 2021 from 2 biomedical companies, totalling $37.66, including $37.66 from  Genentech, Inc.
    Subjects: Paraneoplastic Syndromes, Ocular; Autoantibodies; Autoantigens; Autoimmune Diseases; Diagnostic Techniques, Ophthalmological; Retina
    Categories: Diagnosis; Immunology; Blood; Etiology; Therapy
    Cancer-associated retinopathy: update on pathogenesis and therapy. (2011)
    Progress Toward Precisely Diagnosing Autoimmune Retinopathy. (2018)

  2. Shields, Carol L   Ophthalmology  Google Publications
    Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
    Physician  Highly Published  Case Reports 
    Medical school: University of Pittsburgh School of Medicine (MD, 1979)
    Medicare Accepted
    Disclosed payments from biomedical company (Carl Zeiss Meditec, Inc.) in 2021 for $13,150
    Subjects: Paraneoplastic Syndromes, Ocular; Vitelliform Macular Dystrophy; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Melanoma
    Categories: Diagnosis; Drug Therapy; Administration & Dosage; Adverse Effects; Chemically Induced; Etiology
    ACUTE EXUDATIVE PARANEOPLASTIC POLYMORPHOUS VITELLIFORM MACULOPATHY DURING VEMURAFENIB AND PEMBROLIZUMAB TREATMENT FOR METASTATIC MELANOMA. (2019)
    Acute exudative paraneoplastic polymorphous vitelliform maculopathy in five cases. (2012)

  3. Jampol, Lee M   Ophthalmology  Google Publications
    Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. Top Hospital
    Physician  Highly Published  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 86.9/100
    Subjects: Paraneoplastic Syndromes, Ocular; Adenocarcinoma; Autoantibodies; Autoantigens; Autoimmune Diseases; Cell Proliferation
    Categories: Pathology; Immunology; Adverse Effects; Drug Therapy; Physiopathology; Antagonists & Inhibitors
    Autoimmune retinopathy and antiretinal antibodies: a review. (2014)
    Diffuse Uveal Melanocytic Proliferation With Primary Vitreoretinal Lymphoma. (2019)

  4. Sarraf, David   Ophthalmology  Google Publications
    Department of Ophthalmology, Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, CA.
    Physician  Highly Published  Case Reports 
    Medical school: Other (MD, 1990)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 63/100
    Disclosed payments in 2021 from 11 biomedical companies, totalling $38,377.08, including $22,000 from  OPTOVUE, INC.
    Subjects: Paraneoplastic Syndromes, Ocular; Cysts; Iris Diseases; Melanocytes; Melanoma; Optic Nerve Diseases
    Categories: Diagnosis; Diagnostic Imaging; Pathology; Secondary
    Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management. (2013)
    Bilateral diffuse uveal melanocytic proliferation with multiple iris cysts. (2014)

  5. Pittock, Sean J   Neurology  Google Publications
    Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota; Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota. Top Hospital
    Physician  Highly Published  Case Reports 
    Medical school: Other (MD, 1993)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 79.7/100
    Disclosed payments in 2021 from 25 biomedical companies, totalling $23,667.74, including $9,164.38 from  Horizon Therapeutics plc
    Subjects: Paraneoplastic Syndromes, Ocular; Autoantibodies; Cell Proliferation; Eye Diseases; Hydrolases; Immunoglobulin G
    Categories: Immunology; Blood; Drug Effects; Pathology; Pharmacology; Therapy
    A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes. (2012)
    Collapsin Response-Mediator Protein 5-Associated Retinitis, Vitritis, and Optic Disc Edema. (2020)

  6. Mruthyunjaya, Prithvi   Ophthalmology  Google Publications
    Byers Eye Institute, Stanford University School of Medicine, California, USA. Top Hospital
    Physician  Case Reports 
    Medical school: Other (MD, 1996)
    Medicare Accepted
    Disclosed payments in 2021 from 6 biomedical companies, totalling $8,151.32, including $5,684.84 from  Alcon Vision LLC
    Subjects: Paraneoplastic Syndromes, Ocular; Autoimmune Diseases; Fluorescein Angiography; Hematologic Diseases; Multimodal Imaging; Neoplasms
    Categories: Diagnosis; Complications; Methods; Etiology; Pathology
    Multimodal imaging in non-paraneoplastic autoimmune retinopathy. (2019)
    Retinal manifestations of oncologic and hematologic conditions. (2012)

  7. Materin, Miguel A   Ophthalmology  Google Publications
    Department of Ophthalmology and Visual Science, Yale University, New Haven, Connecticut. Top Hospital
    Physician  Case Reports 
    Subjects: Paraneoplastic Syndromes, Ocular; Carcinoma; Melanocytes; Night Blindness; Ovarian Neoplasms; Scotoma
    Categories: Etiology; Pathology; Secondary; Complications
    BILATERAL DIFFUSE UVEAL MELANOCYTIC PROLIFERATION: A CASE REPORT. (2017)
    A 71-year-old woman with decreased vision, nyctalopia, and peripheral vision loss. (2016)

  8. Pulido, Jose S   Urology  Google Publications
    Department of Ophthalmology, Mayo Clinic College of Medicine, Rochester, Minnesota. Top Hospital
    Physician  Highly Published  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 85/100
    Disclosed payments in 2021 from 21 biomedical companies, totalling $728.88, including $445.71 from  Dendreon Pharmaceuticals LLC
    Subjects: Paraneoplastic Syndromes, Ocular; Melanocytes; Adenocarcinoma; Autoantibodies; Cell Proliferation; Endometrial Neoplasms
    Categories: Immunology; Pathology; Diagnosis; Blood; Drug Effects; Drug Therapy
    A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes. (2012)
    Collapsin Response-Mediator Protein 5-Associated Retinitis, Vitritis, and Optic Disc Edema. (2020)

  9. Duvoisin, Robert M   Emergency Medicine  Google Publications
    Department of Chemical Physiology & Biochemistry, Oregon Health & Science University, Portland, OR, United States of America. Top Hospital
    Physician  Highly Published  Case Reports 
    Subjects: Autoantibodies; Paraneoplastic Syndromes, Ocular; TRPM Cation Channels; Melanoma; Autoantigens; Epitopes
    Categories: Immunology; Blood; Diagnosis; Metabolism; Pathology; Secondary
    Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy. (2020)
    Serum TRPM1 autoantibodies from melanoma associated retinopathy patients enter retinal on-bipolar cells and attenuate the electroretinogram in mice. (2013)

  10. Winters, Jeffrey L   Blood Banking & Transfusion Medicine  Google Publications
    Physician  Highly Published  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 79.7/100
    Subjects: Paraneoplastic Syndromes, Ocular; Melanocytes; Adenocarcinoma; Cell Proliferation; Conjunctival Diseases; Endometrial Neoplasms
    Categories: Pathology; Immunology; Complications; Blood; Drug Effects; Pharmacology
    A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes. (2012)
    The potential role of plasma exchange as a treatment for bilateral diffuse uveal melanocytic proliferation: a report of two cases. (2011)

  11. Singh, Arun D   Ophthalmology  Google Publications
    Physician  Case Reports 
    Medical school: Other (MD, 1984)
    Medicare Accepted
    Disclosed payments from biomedical company (Sight Sciences, Inc.) in 2021 for $78.63
    Subjects: Paraneoplastic Syndromes, Ocular; Autoantibodies; Melanoma; Retinal Bipolar Cells; Retinal Neoplasms; Skin Neoplasms
    Categories: Immunology; Pathology; Secondary
    Paraneoplastic vitelliform retinopathy: clinicopathologic correlation and review of the literature. (2012)
    Autoantibody against transient receptor potential M1 cation channels of retinal ON bipolar cells in paraneoplastic vitelliform retinopathy. (2012)

  12. Yonekawa, Yoshihiro   Ophthalmology  Google Publications
    Neuro-Ophthalmology Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts. Top Hospital
    Physician  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 99/100
    Disclosed payments in 2021 from 7 biomedical companies, totalling $11,664.2, including $7,350 from  Alcon Vision LLC
    Subjects: Adenocarcinoma; Paraneoplastic Syndromes, Ocular; Carcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Lung Neoplasms; Melanocytes
    Categories: Complications; Pathology; Diagnosis; Etiology
    Inferior peripheral nonperfusion in bilateral diffuse uveal melanocytic proliferation. (2013)
    Ocular flutter as the presenting sign of lung adenocarcinoma. (2014)

  13. Dalal, Monica D   Ophthalmology  Google Publications
    National Eye Institute, National Institutes of Health, Bethesda, MD.
    Physician  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 86/100
    Subjects: Paraneoplastic Syndromes, Ocular; Autoantibodies; Autoantigens; Autoimmune Diseases; Melanoma; Neoplasms, Unknown Primary
    Categories: Diagnosis; Immunology; Blood; Pathology; Secondary
    Autoimmune retinopathy. (2014)
    Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach. (2013)

  14. Aronow, Mary E   Ophthalmology  Google Publications
    Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.
    Physician  Case Reports 
    Subjects: Paraneoplastic Syndromes, Ocular; Autoantibodies; Melanoma; Retinal Bipolar Cells; Retinal Neoplasms; Skin Neoplasms
    Categories: Immunology; Pathology; Secondary
    Paraneoplastic vitelliform retinopathy: clinicopathologic correlation and review of the literature. (2012)
    Autoantibody against transient receptor potential M1 cation channels of retinal ON bipolar cells in paraneoplastic vitelliform retinopathy. (2012)

  15. Shildkrot, Yevgeniy   Ophthalmology   Google Publications
    Massachusetts Eye and Ear Infirmary, Retina Service, Harvard Medical School, Boston, MA 02114, USA.  Top Hospital
    Physician  Case Reports 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $152.36, including $97.18 from  Horizon Therapeutics plc
    Subjects: Paraneoplastic Syndromes, Ocular; Adenocarcinoma; Endometrial Neoplasms; Melanocytes; Uveal Diseases
    Categories: Pathology; Diagnosis; Etiology; Therapy
    Cancer-associated retinopathy: update on pathogenesis and therapy. (2011)
    Inferior peripheral nonperfusion in bilateral diffuse uveal melanocytic proliferation. (2013)

  16. Khanna, Sangeeta   Ophthalmology  Google Publications
    Department of Ophthalmology and Neurology, Saint Louis University, St Louis, MO, USA.
    Physician  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 70/100
    Disclosed payments from biomedical company (Sight Sciences, Inc.) in 2021 for $17.25
    Subjects: Melanoma; Paraneoplastic Syndromes, Ocular; Programmed Cell Death 1 Receptor; Skin Neoplasms
    Categories: Diagnosis; Secondary; Antagonists & Inhibitors; Complications; Etiology; Pathology
    Metastatic Cutaneous Melanoma Presenting With Melanoma-Associated Retinopathy. (2019)
    Normalization of electroretinogram and symptom resolution of melanoma-associated retinopathy with negative autoantibodies after treatment with programmed death-1 (PD-1) inhibitors for metastatic melanoma. (2021)

  17. Niles, Richard M   Family Medicine  Google Publications
    Physician  Case Reports 
    Disclosed payments from biomedical company (Avanir Pharmaceuticals, Inc.) in 2021 for $17.82
    Subjects: Melanocytes; Paraneoplastic Syndromes, Ocular; Adenocarcinoma; Cell Proliferation; Conjunctival Diseases; Endometrial Neoplasms
    Categories: Pathology; Immunology; Complications; Blood; Drug Effects; Pharmacology
    A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytes. (2012)
    Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation. (2013)

  18. Choudhry, Netan   Ophthalmology  Google Publications
    Physician  Case Reports 
    Subjects: Paraneoplastic Syndromes, Ocular; Branchioma; Breast Neoplasms; Head and Neck Neoplasms; Macula Lutea; Multimodal Imaging
    Categories: Diagnosis; Pathology; Blood Supply; Methods
    Multimodal Imaging Features in Acute Exudative Paraneoplastic Polymorphous Vitelliform Maculopathy. (2016)
    Diagnostic and Therapeutic Challenges. (2022)

  19. Shields, Jerry A   Ophthalmology  Google Publications
    Physician  Case Reports 
    Subjects: Paraneoplastic Syndromes, Ocular; Vitelliform Macular Dystrophy; Retinal Detachment
    Categories: Diagnosis; Etiology
    Acute exudative paraneoplastic polymorphous vitelliform maculopathy in five cases. (2012)
    Diagnostic and therapeutic challenges. (2012)

  20. Jeffrey, Brett G   Family Medicine  Google Publications
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
    Physician  Case Reports 
    Subjects: Autoantibodies; Paraneoplastic Syndromes, Ocular; TRPM Cation Channels; Autoantigens; Melanoma; Neoplasms, Unknown Primary
    Categories: Immunology; Blood; Diagnosis; Metabolism; Pathology; Secondary
    Serum TRPM1 autoantibodies from melanoma associated retinopathy patients enter retinal on-bipolar cells and attenuate the electroretinogram in mice. (2013)
    Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach. (2013)

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
  2. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);